- Home
- XPER vs MDCX Comparison
XPER vs MDCX Comparison
Compare XPER & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPER
- MDCX
- Stock Information
- Founded
- XPER 1990
- MDCX 2008
- Country
- XPER United States
- MDCX Canada
- Employees
- XPER N/A
- MDCX N/A
- Industry
- XPER Semiconductors
- MDCX
- Sector
- XPER Technology
- MDCX
- Exchange
- XPER Nasdaq
- MDCX Nasdaq
- Market Cap
- XPER 463.5M
- MDCX 29.7M
- IPO Year
- XPER 2003
- MDCX N/A
- Fundamental
- Price
- XPER $10.33
- MDCX $2.51
- Analyst Decision
- XPER Strong Buy
- MDCX Strong Buy
- Analyst Count
- XPER 3
- MDCX 1
- Target Price
- XPER $19.00
- MDCX $10.00
- AVG Volume (30 Days)
- XPER 425.1K
- MDCX 13.6K
- Earning Date
- XPER 02-26-2025
- MDCX 01-01-0001
- Dividend Yield
- XPER N/A
- MDCX N/A
- EPS Growth
- XPER N/A
- MDCX N/A
- EPS
- XPER N/A
- MDCX N/A
- Revenue
- XPER $508,559,000.00
- MDCX N/A
- Revenue This Year
- XPER N/A
- MDCX N/A
- Revenue Next Year
- XPER $2.28
- MDCX N/A
- P/E Ratio
- XPER N/A
- MDCX N/A
- Revenue Growth
- XPER N/A
- MDCX N/A
- 52 Week Low
- XPER $6.89
- MDCX $1.80
- 52 Week High
- XPER $12.29
- MDCX $3.23
- Technical
- Relative Strength Index (RSI)
- XPER 58.37
- MDCX N/A
- Support Level
- XPER $9.90
- MDCX N/A
- Resistance Level
- XPER $10.42
- MDCX N/A
- Average True Range (ATR)
- XPER 0.35
- MDCX 0.00
- MACD
- XPER -0.04
- MDCX 0.00
- Stochastic Oscillator
- XPER 39.18
- MDCX 0.00
About XPER Xperi Inc.
Xperi Inc consumer and entertainment technology company. Its offering comprises a portfolio of software and services. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.